ERBB2 and metastatic malignant neoplasm in the lymph nodes: Besides, as shown in Figure 3A–3K, high expression of SURF4 was observed in female (P = 0.026), patients without lymph node metastasis (P = 0.037), HER2 overexpression type (P < 0.001), and deceased patients (P = 0.016).